The investment is led by Wellington Partners.
Neuway Pharma, the first spin-out from Life Science Inkubator (LSI) in Bonn, has raised €2.7m in its series A, led by Wellington Partners, a venture capital firm based in London, Munich and Zurich. The firm has about €800m under management.
Neuway was founded in April 2014, with main shareholders LSI and Heiko Manninga, the company’s initial managing director and chief scientific officer. Lucio van Rooijen, who had advised LSI for the last 12 months on the spin-out, and Stephan Rapp,…
